Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BMY |
---|---|---|
09:32 ET | 223416 | 77.26 |
09:34 ET | 74480 | 77.275 |
09:36 ET | 92990 | 77.34 |
09:38 ET | 67259 | 77.13 |
09:39 ET | 105370 | 77.14 |
09:41 ET | 79739 | 77.18 |
09:43 ET | 47740 | 77.18 |
09:45 ET | 57197 | 77.27 |
09:48 ET | 87549 | 77.26 |
09:50 ET | 56666 | 77.265 |
09:52 ET | 46553 | 77.16 |
09:54 ET | 81525 | 77.28 |
09:56 ET | 78858 | 77.2 |
09:57 ET | 106545 | 77.21 |
09:59 ET | 153090 | 77.44 |
10:01 ET | 69663 | 77.245 |
10:03 ET | 61530 | 77.235 |
10:06 ET | 56873 | 77.245 |
10:08 ET | 45326 | 77.15 |
10:10 ET | 33225 | 77.11 |
10:12 ET | 33240 | 77.13 |
10:14 ET | 48931 | 77.055 |
10:15 ET | 47038 | 77.095 |
10:17 ET | 70106 | 77.09 |
10:19 ET | 44883 | 76.985 |
10:21 ET | 40372 | 76.98 |
10:24 ET | 30762 | 77.07 |
10:26 ET | 38602 | 77.05 |
10:28 ET | 33079 | 77.05 |
10:30 ET | 48609 | 77.22 |
10:32 ET | 77507 | 77.31 |
10:33 ET | 66899 | 77.235 |
10:35 ET | 54068 | 77.38 |
10:37 ET | 43581 | 77.255 |
10:39 ET | 53103 | 77.31 |
10:42 ET | 58542 | 77.31 |
10:44 ET | 31986 | 77.29 |
10:46 ET | 29328 | 77.14 |
10:48 ET | 38165 | 77.2399 |
10:50 ET | 67094 | 77.085 |
10:51 ET | 47420 | 77.075 |
10:53 ET | 30903 | 77.115 |
10:55 ET | 38274 | 77.13 |
10:57 ET | 39328 | 77.15 |
11:00 ET | 43223 | 77.13 |
11:02 ET | 32480 | 77.1 |
11:04 ET | 35054 | 77.12 |
11:06 ET | 74865 | 77.085 |
11:08 ET | 214808 | 77.2 |
11:09 ET | 49849 | 77.24 |
11:11 ET | 49280 | 77.22 |
11:13 ET | 37231 | 77.145 |
11:15 ET | 71601 | 77.2 |
11:18 ET | 64304 | 77.195 |
11:20 ET | 34014 | 77.245 |
11:22 ET | 49440 | 77.21 |
11:24 ET | 33029 | 77.19 |
11:26 ET | 30233 | 77.24 |
11:27 ET | 36203 | 77.195 |
11:29 ET | 50741 | 77.27 |
11:31 ET | 61068 | 77.32 |
11:33 ET | 39254 | 77.33 |
11:36 ET | 25799 | 77.4 |
11:38 ET | 63908 | 77.35 |
11:40 ET | 16996 | 77.37 |
11:42 ET | 33397 | 77.41 |
11:44 ET | 91471 | 77.415 |
11:45 ET | 49914 | 77.44 |
11:47 ET | 27391 | 77.3 |
11:49 ET | 30530 | 77.3 |
11:51 ET | 17827 | 77.28 |
11:54 ET | 20540 | 77.305 |
11:56 ET | 26209 | 77.305 |
11:58 ET | 23367 | 77.33 |
12:00 ET | 18109 | 77.3 |
12:02 ET | 27519 | 77.28 |
12:03 ET | 28360 | 77.28 |
12:05 ET | 18636 | 77.25 |
12:07 ET | 16087 | 77.21 |
12:09 ET | 17260 | 77.255 |
12:12 ET | 19876 | 77.1901 |
12:14 ET | 21963 | 77.21 |
12:16 ET | 15084 | 77.2 |
12:18 ET | 29031 | 77.095 |
12:20 ET | 22962 | 77.085 |
12:21 ET | 18008 | 77.1 |
12:23 ET | 17337 | 77.07 |
12:25 ET | 19054 | 77.045 |
12:27 ET | 19947 | 77.01 |
12:30 ET | 14302 | 77.03 |
12:32 ET | 21904 | 76.96 |
12:34 ET | 14174 | 77.05 |
12:36 ET | 15668 | 77.08 |
12:38 ET | 18714 | 77.11 |
12:39 ET | 21765 | 77.17 |
12:41 ET | 14885 | 77.12 |
12:43 ET | 15693 | 77.08 |
12:45 ET | 23678 | 77.055 |
12:48 ET | 20286 | 76.985 |
12:50 ET | 17517 | 77 |
12:52 ET | 19396 | 76.91 |
12:54 ET | 13858 | 76.88 |
12:56 ET | 21599 | 76.915 |
12:57 ET | 21363 | 76.8705 |
12:59 ET | 41201 | 76.9 |
01:01 ET | 21729 | 76.891 |
01:03 ET | 53028 | 76.885 |
01:06 ET | 67845 | 76.8 |
01:08 ET | 13705 | 76.79 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Bristol-Myers Squibb Co | 162.2B | 27.3x | +3.27% |
Sanofi SA | 137.0B | 19.9x | +7.84% |
GSK plc | 111.7B | 17.8x | +36.01% |
AstraZeneca PLC | 202.6B | -201.2x | -50.95% |
Novartis AG | 214.2B | 8.4x | +30.61% |
Merck & Co Inc | 236.6B | 17.2x | +28.17% |
Bristol-Myers Squibb Company is a biopharmaceutical company. The Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company offers products for a range of therapeutic classes, which include oncology, immunology, cardiovascular and fibrosis. The Company’s pharmaceutical products include chemically-synthesized or small molecule drugs and products produced from biological processes, called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. The Company’s products include Revlimid, Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Sprycel, Yervoy, Abraxane, Empliciti, Reblozyl, Inrebic, Onureg, Zeposia, Vidaza, Baraclude and Breyanzi. Its products are sold to wholesalers, distributors, pharmacies, retailers, hospitals, clinics and government agencies.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $162.2B |
---|---|
Revenue (TTM) | $47.0B |
Shares Outstanding | 2.1B |
Dividend Yield | 2.81% |
Annual Dividend Rate | 2.1600 USD |
Ex-Dividend Date | 03-31-22 |
Pay Date | 05-02-22 |
Beta | 0.46 |
EPS | $2.82 |
Book Value | $16.70 |
P/E Ratio | 27.3x |
Price/Sales (TTM) | 3.5 |
Price/Cash Flow (TTM) | 9.6x |
Operating Margin | 18.97% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.